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More than 1% of all adults in the United States are currently 
in a jail or prison. This mass incarceration, particularly of 
African American men, fosters conditions that facilitate the 
spread of HIV in communities where both HIV and incarcer-
ation are endemic. Recognition of the role of mass incarcera-
tion in the perpetuation of the HIV epidemic is essential to 
development of effective HIV prevention policies.
The United States is home to 5% of the global popula-tion but accounts for 25% of the world’s prisoners [1]. 
Per capita, the United States incarcerates more of its own 
people than any other nation, with 1 in 99 adults currently 
behind bars, in either a jail or a prison; an additional 4 million 
people are supervised under parole or probation [1-3]. The 
consequences of this large-scale incarceration, beyond the 
considerable financial cost to taxpayers, are multiple and 
not always obvious. The policies that have led to mass incar-
ceration have affected minorities and those living in poverty 
the most, and this unevenness in the application of the law 
has perpetuated economic and other disparities, as ex-
offenders struggle to find work, housing, and stable medical 
care. In addition, the incarceration of a sizable proportion of 
the community causes societal disruptions that foster the 
spread of infectious diseases, including HIV.  
This commentary describes how the coincident epidem-
ics of incarceration and HIV infection have led to a concen-
tration of HIV in US prisons and jails, which facilitates the 
spread of HIV infection in communities where both incar-
ceration and HIV are prevalent. 
Mass Incarceration in the United States
Prior to 1970, the rate of incarceration in the United States 
was similar to that of other nations in North America and 
Europe. Then a succession of legislative and policy changes, 
crafted as a “war on drugs,” began in the early 1960s and 
accelerated over the following 2 decades, resulting in a 
dramatic expansion of the criminal justice system and an 
increase in the number of people behind bars (Figure 1) 
[4, 5]. During this period, laws punishing illicit drug use 
were enacted and toughened, sentences were lengthened, 
and policing tactics became more aggressive. To house the 
resulting explosion in incarceration—a 700% increase from 
1972 to 2013—more prisons were constructed [4, 5]. 
This shift toward a more punitive and less rehabilitative 
approach to public safety not only led to large-scale impris-
onment but also disproportionately affected racial and eth-
nic minorities and people living in poverty. The United States 
currently incarcerates a greater proportion of its black popu-
lation than did South Africa during the Apartheid era [6]. 
States with the highest rates of incarceration are found in 
the Southern region of the United States. 
Drug laws, in particular, have led to a substantial increase 
in incarceration rates for African American men. In 2012, the 
incarceration rate per 100,000 African American men was 
2,841, compared to 463 for white men [7]. African American 
men are estimated to have a lifetime risk of imprisonment of 
1 in 3, compared to 1 in 6 for Latino men and 1 in 17 for white 
men [8]. Similar trends are seen among women, with an 
estimated lifetime risk of incarceration for African American 
women at 1 in 18, compared to 1 in 45 for Latina women and 
1 in 111 for white women. 
High Concentration of HIV Infection Within 
Correctional Facilities
At the same time that incarceration rates were increas-
ing in the United States, so too was the incidence of HIV 
infection. Initially confined to populations of men who have 
sex with men in large cities on the East and West coasts, 
HIV infection quickly entered into and spread among net-
works of injecting drug users and those using crack cocaine. 
Consequently, the policies that were established to arrest 
and imprison those involved in the use and trafficking of 
illicit substances inadvertently targeted for incarceration 
those with an elevated risk of HIV and viral hepatitis infec-
tions, including substance users, many of whom suffer from 
mental illness.  
At present, the national prevalence of HIV infection in 
state and federal prisons is estimated at 1.5%—approxi-
mately 5-fold greater than the rate in the general US 
population—but rates vary greatly by state [9]. In a study 
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performed by our group at the University of North Carolina 
(UNC) at Chapel Hill, excess blood specimens that remained 
after routine medical screening of over 23,000 adult men 
and women entering the North Carolina prison system in 
2008–2009 were anonymously tested for HIV antibodies 
[10]. Overall, 1.45% of inmates entering the prison system 
during this period tested HIV seropositive; this rate is many 
times greater than the state’s HIV prevalence rate but on par 
with the average for prisons nationally. 
The flip side of the concentration of HIV infection in 
our nation’s correctional facilities is the high prevalence of 
imprisonment among persons living with HIV. According to 
one study, an estimated 14% of all persons living with HIV 
infection in the United States, and 20% of African American 
HIV-infected individuals, pass through a jail or prison each 
year (as do one-third of all those identified with chronic 
hepatitis C virus infection) [11]. 
 More recent data indicate that in North Carolina, and in 
the nation as a whole, incarceration rates have started to 
drop, as have the number of state and federal prison inmates 
with HIV infection. There are less data available on rates 
of HIV-infected persons in jails, which mostly house those 
who have not yet been tried or who have been convicted but 
are completing relatively short sentences. The high cost of 
maintaining jails and prisons and the overcrowding of cor-
rectional facilities have been the driving forces behind the 
small but meaningful decline in the incarcerated population. 
HIV Screening and Treatment During Incarceration
In terms of HIV prevention and treatment, incarcera-
tion provides opportunities as well as challenges. Ideally, 
HIV screening at the time of jail or prison entry can iden-
tify those with previously undiagnosed infection, allow 
for the initiation of secondary prevention counseling and 
treatment, and promote linkage to community care prior 
to release. Approximately 20% of those infected with HIV 
in the United States are unaware that they are HIV-positive 
[12], and screening for HIV infection at prison entry is seen 
as an opportunity to identify some of these undiagnosed 
individuals. In many states, including North Carolina, HIV 
testing is mandatory for all individuals entering prison. In 
our study, which collected and HIV-tested excess blood 
from over 23,000 prison entrants in North Carolina, we 
found 320 individuals who were HIV seropositive at screen-
ing [10]. However, all but 20 were already known to the state 
health authorities as being HIV-infected. Therefore, testing 
of prisoners, at least in North Carolina, is more likely to iden-
tify those already known to be infected rather than to detect 
undiagnosed cases. For jails, the situation may be differ-
ent, given the larger number of people who are jailed. HIV 
screening procedures in jails vary, including among those 
in North Carolina. Short jail stays and limited resources for 
testing and discharge planning challenge HIV screening in 
jails, although many jails do provide rapid HIV testing. 
As mentioned previously, those in jail or prison who are 
identified as being HIV-infected, whether or not they are 
newly diagnosed, can be offered care during their incarcera-
tion. Effective HIV therapies are almost always available in 
prisons—both state and federal—and available data suggest 
that treatment for HIV-infected prison inmates is as good as, 
if not better, than treatment in community-based HIV clin-
ics. Additionally, HIV-related mortality has declined among 
prisoners in parallel with the decrease seen in the general 
population [9, 13]. HIV treatment outcomes in the nation’s 
figure 1.
US State and Federal Prison Population, 1925–2012
Source: Warren J [1].
many thousands of jails are harder to assess and are likely 
to vary greatly. Jails are operated by towns, municipalities, 
or counties and are not always able to or committed to mak-
ing HIV therapy available to inmates in a timely manner. In 
addition, jail budgets may not be able to accommodate the 
relatively high cost of HIV medications. Therefore, interrup-
tions in HIV therapy during jail stays are common. 
Linkage to Community Care
 While HIV care in prisons is generally effective, a major 
challenge in HIV correctional care is maintaining the ben-
efits of treatment achieved during incarceration following 
community reentry. Ample data demonstrate that a large 
proportion of HIV-infected individuals who leave state 
prisons experience a loss of control of their HIV infection 
[14-16]. We found that, among HIV-infected individuals who 
were released from prison and later re-incarcerated, plasma 
HIV RNA levels were significantly greater at the time of re-
incarceration than at the time of release [14]. Furthermore, 
rates of viral suppression are low for HIV-infected individu-
als who are frequently involved in the criminal justice system 
[17].
In Texas, HIV-infected prisoners are given a 10-day sup-
ply of their HIV medication when they are released from 
prison, and all qualify for free antiretrovirals via the state 
AIDS Drug Assistance Program. However, one study found 
that only 30% of HIV-infected individuals picked up their 
antiretroviral medication within 60 days following commu-
nity re-entry (see Figure 2) [16]. 
As a result of this unsettling finding, our research group 
at UNC working with collaborators at Texas Christian 
University launched a study funded by the National Institute 
of Drug Abuse at the National Institutes of Health to develop 
and test an intervention to improve linkage to HIV care after 
release from prison. This randomized trial enrolled over 
400 men and women with suppressed HIV viral load who 
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were being released from state prisons in North Carolina 
or Texas. The purpose of the intervention was to increase 
the motivation of individuals to receive HIV care after re-
entering the community. Techniques included motivational 
interviewing, a reduction in barriers to care using brief case 
management, and support of adherence to HIV medications 
via study-supplied cell phones that would send reminders 
before scheduled doses. In comparison to a control group 
that received routine prerelease discharge planning, we 
found no significant effect of the intervention on the propor-
tion of released individuals with an undetectable HIV RNA 
level 6 months after release [18]. These data echo results 
of a smaller study we conducted examining the effects of 
an intensive bridging case management program in North 
Carolina for HIV-infected men and women being released 
from state prison [19]. That study also found no difference 
in the rate of engagement in medical care after release 
between a group that received the bridging case manage-
ment and a group receiving standard discharge planning. 
These findings suggest that interventions focused on 
motivation and facilitation, even those that are well designed 
and rigorously administered, are insufficient to overcome 
forces that impede ongoing adherence to HIV medications 
and care. Such forces are pervasive and include poverty, 
homelessness, discrimination, stigma, mental illness, and 
substance abuse. Societal remedies for such ills are typically 
nonexistent and, when present, are underfunded and diffi-
cult to access. 
Mass Incarceration and the Spread of HIV
Sexual transmission of HIV during incarceration is a con-
cern given the potential “perfect storm” in many correctional 
systems of a relatively high prevalence of HIV infection 
coupled with policies that ban condoms and clean injecting 
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equipment. However, the extent to which HIV is acquired in 
jails and prisons is unclear, and the available data suggest 
that the overwhelming majority of HIV-infected persons in 
jails or prisons entered these facilities with HIV. Despite HIV 
testing of inmates being conducted at entry and release in 
many states, including North Carolina, reports describing 
seroconversion rates during incarceration have not been 
made public. Most experts in this field believe that HIV 
acquisition in prison and jails is rare and that public percep-
tions of this phenomenon are disproportionate to its fre-
quency [20].
Social Disruption in Communities
A potentially greater effect of mass incarceration on the 
spread of HIV infection, albeit one that is more difficult to 
measure, is the social disruption caused by the imprisonment 
of a large proportion of men in a community. In areas and 
populations where incarceration rates are high, the social 
order is altered as sex ratios shift and men go “missing” from 
their communities [21]. In many communities, particularly 
those that have a large African American population, there 
are only 6 to 8 men for every 10 women. Such an imbalance 
in the ratio of men to women can affect sexual behavior 
and has been associated with concurrency of partnerships, 
which can foster the transmission of HIV and other sexually 
transmitted infections. A scarcity of men places women at 
a disadvantage and can undercut their power to negotiate 
partner monogamy and condom use. Women faced with 
fewer options may also form partnerships with men of lower 
socioeconomic status, including those who are unemployed 
or who have been recently incarcerated [21-22].
Incarceration can also directly disrupt relationships that 
may have been protective against sexually transmitted 
infections. Work by Khan and colleagues in North Carolina 
describes how incarceration of a partner may end a rela-
tionship, leading the remaining partner to seek a new rela-
tionship [23-24]. In an area where sexually transmitted 
infections may be relatively prevalent, new relationships 
carry an increased risk of exposure and infection. Similarly, 
following incarceration and subsequent release, the individ-
ual who is re-entering the community may also form a new 
partnership, possibly risking exposure to sexually transmit-
ted infections.
As stated above, suppression of HIV replication during 
incarceration is the rule rather than the exception. Upon 
release, it is the reverse, with the risk of viral rebound 
increasing over time. Coincident with a return of viremia is 
an increase in infectiousness. Therefore, the failure to main-
tain effective management of HIV infection following incar-
ceration threatens not only individual health but also public 
health as released individuals return to their communities 
and establish or re-establish sexual partnerships. 
Interventions to Mitigate the Effects of Mass 
Incarceration on HIV Transmission
In highlighting the ways in which HIV and mass incarcer-
ation intersect, potential opportunities for intervention can 
be identified. As discussed, counseling and linkage programs 
for HIV-infected persons involved in the criminal justice sys-
tem—while well-intentioned and pragmatic—have not been 
proven to be highly effective. Nonetheless, these initiatives 
may be beneficial to some, perhaps in ways that are difficult 
to measure, which may justify their continuation. Additional 
research may also lead to the development of scalable 
programs that could have greater impact. There is a clear 
need for jails to be empowered and funded to improve HIV 
screening, HIV care, and rudimentary community linkage to 
HIV services. 
However, to achieve a major shift from the current cycle 
in which mass incarceration, particularly of racial and ethnic 
minority men, disrupts and tears at the social fabric, inter-
vention needs to be large-scale and collective, rather than 
targeted and individualized. The most obvious place to start 
is with mass incarceration itself. Changes in public policy that 
reduce the staggering rate at which the country imprisons 
its citizens would be expected to impact the HIV epidemic. 
There is now growing support from across the political spec-
trum for criminal justice reform, given recognition that the 
current situation is unaffordable, unsustainable, and unten-
able. Changes in sentencing laws are starting to address 
racial and ethnic disparities, and the mandatory minimums 
that sent many low-level offenders to prison for years are 
being abandoned so that judges can apply their discretion 
when sentencing. Diversion programs are keeping more peo-
ple from becoming incarcerated, and drug courts are help-
ing to link those with substance use disorders to mandated 
care rather than time behind bars. These and other initia-
tives are behind the start of a downtrend in the number of 
people imprisoned in the United States. They can therefore 
be expected to reduce the profound disruptions caused by 
the mass incarceration that fosters HIV transmission. 
figure 2.
Percent of HIV-Infected Individuals Released From Prison 
Who Filled an Antiretroviral Prescription in the Days 
Following Release (N = 2,115)
Source: Baillargeon J, et al [16].
Conclusion
Mass incarceration in the United States powers the HIV 
epidemic. Policies and laws leading to high rates of incarcer-
ation, especially of African American men, have numerous 
adverse effects on communities and society, including the 
creation and promotion of circumstances that heighten the 
risk of transmission of HIV and other sexually transmitted 
diseases. To fully address the HIV epidemic, the epidemic of 
incarceration must be addressed.  
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